72 results
Page 3 of 4
424B4
cgb lj9jgpobji
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
6s0ttd8bii2j468pqmn
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
1p9zfogf1138euw
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
ugeu ncxyi
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
x05w9nn xu
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
g40p tshn50nlb63
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
xs8qsvsu
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
frk6apdv
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
auwappo1q8cva
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
vtj2zv 0zv
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.12.1
lwp1n brrsaq0d9devg
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-2.1
68rf2i8ubyhg2o84
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.11.1
v2fforq202
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.3
19dghmm52tw0fqb lj
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-4.1.1
t4z1nxpv91kdumiy v9j
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-4.1
j6qnv6
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
qudzq 1nzgpanf
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.2
gojp 5z3gk1jekjxd
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
97pmbtltybs50485tr
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
g3hzu5v
23 Jun 20
Registration statement (foreign)
5:21pm